EUPRAXIA PHARMACEUTICALS INC. Interest Expense
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-03-13
| Period end | Interest Expense 12 month |
|---|---|
| 2025-12-31 | $0.00 40-F · filed 2026-03-13 |
| 2024-12-31 | $603.57K 40-F · filed 2026-03-13 |
| 2023-12-31 | $1.17M 40-F · filed 2025-03-20 |
| 2022-12-31 | $982.86K 40-F · filed 2024-04-01 |